ERBB2 and breast carcinoma: As an example, as HER2 protein overexpression or gene amplification in the primary tumor is currently required for administering anti-HER2 treatment in breast cancer [13], HER2 status on CTCs has also been investigated in breast cancer using CellSearch® and other technologies [14-18].